NCT05364099

Suprascapular Nerve Block for Treatment of Shoulder Pain in Individuals With Spinal Cord Injuries

• Status: Withdrawn
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University of Miami · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the effectiveness and safety of using suprascapular nerve block for individuals with chronic spinal cord injury who have chronic shoulder pain.

Conditions

• Chronic Shoulder Pain

Interventions

Type	Name	Description
DRUG	Lidocaine 1% Injectable Solution	2.5 ml of 1% Lidocaine will be administered via injection in suprascapular nerve in the suprascapular notch
DRUG	Triamcinolone Injection	0.5 ml 40mg/ml Triamcinolone will be administered via injection in suprascapular nerve in the suprascapular notch
PROCEDURE	Suprascapular Nerve Block	This procedure involves injection of a lidocaine and triamcinolone mixture into the suprascapular nerve in the suprascapular notch using ultrasound guidance for proper placement of drugs.

Timeline

• Start date: 2023-11-27
• Primary completion: 2024-01-01
• Completion: 2024-01-01
• First posted: 2022-05-06
• Last updated: 2023-12-06

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study